PX
56
3
L
54
5
PFG
27
7
WMT
68
-2
ZBH
69
15
SHW
42
5
PNW
55
3
INTC
35
4
SIG
52
5
PM
49
8
SCHW
40
3
LNC
28
3
NKE
36
2
BK
60
2
HPE
48
2
SRE
37
9
PYPL
49
4
ACN
54
2
TRV
34
4
AFL
34
6
PX
56
3
L
54
5
PFG
27
7
WMT
68
-2
ZBH
69
15
SHW
42
5
PNW
55
3
INTC
35
4
SIG
52
5
PM
49
8
SCHW
40
3
LNC
28
3
NKE
36
2
BK
60
2
HPE
48
2
SRE
37
9
PYPL
49
4
ACN
54
2
TRV
34
4
AFL
34
6
Financhill
Back

NV5 Global 10K Form

Sell
23

NVEE
NV5 Global

Last Price:
$19.05
Seasonality Move:
-0.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVEE News And Ratings

See the #1 stock for the next 7 days that we like better than NVEE

NVEE Financial Statistics

Sales & Book Value

Annual Sales: $861.7M
Cash Flow: $44.4M
Price / Cash Flow: 20.7
Annual Sales: $12.63
Price / Book: 1.5

Profitability

EPS (TTM): 0.56250
Net Income (TTM): $36.4M
Gross Margin: $430.4M
Return on Equity: 4.62%
Return on Assets: 2.98%

NV5 Global Earnings Forecast

Key NV5 Global Financial Ratios

  • The Gross Profit Margin over the past 14 years for NVEE is 49.94%.
  • The Selling, General & Administrative Expenses for NVEE have been equal to 34.09% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 29.07% of Operating Income.
  • The Net Earning history of NVEE is 5.18% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 10 years.

NV5 Global Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Professional Services
Sector: Industrials
Current Symbol: NVEE
CUSIP: 62945V
Website: nv5.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 2.05
Quick Ratio: 1.96

Price-to-Earnings

Trailing P/E Ratio: 26.43
Forward P/E Ratio: 14.98

NVEE Technical Analysis vs Fundamental Analysis

Sell
23
NV5 Global (NVEE) is a Sell

Is NV5 Global a Buy or a Sell?

  • NV5 Global stock is rated a Sell
    The current NV5 Global [NVEE] share price is $19.03. The Score for NVEE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.